Clinical Trial Update: Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anlotinib, toripalimab, and nab-paclitaxel for locally advanced or metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Neoplasm

Drugs mentioned

• Anlotinib (anlotinib)
• Nab-paclitaxel (paclitaxel protein-bound)
• Toripalimab (Toripalimab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Pancreatic Neoplasm, Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN